PT758241E - Utilizacao de certos derivados de acido metanobisfosfonico para impedir o desprendimento de proteses e a migracao de proteses - Google Patents
Utilizacao de certos derivados de acido metanobisfosfonico para impedir o desprendimento de proteses e a migracao de protesesInfo
- Publication number
- PT758241E PT758241E PT95914495T PT95914495T PT758241E PT 758241 E PT758241 E PT 758241E PT 95914495 T PT95914495 T PT 95914495T PT 95914495 T PT95914495 T PT 95914495T PT 758241 E PT758241 E PT 758241E
- Authority
- PT
- Portugal
- Prior art keywords
- acid derivatives
- certain
- pct
- methanbosphosphonic
- proteses
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9408775A GB9408775D0 (en) | 1994-05-04 | 1994-05-04 | Use of certain methanebisphosphonic acid derivatives to prevent prothesis loosening and prothesis migration |
Publications (1)
Publication Number | Publication Date |
---|---|
PT758241E true PT758241E (pt) | 2002-10-31 |
Family
ID=10754497
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT95914495T PT758241E (pt) | 1994-05-04 | 1995-04-24 | Utilizacao de certos derivados de acido metanobisfosfonico para impedir o desprendimento de proteses e a migracao de proteses |
Country Status (18)
Country | Link |
---|---|
US (1) | US5965547A (pt) |
EP (1) | EP0758241B1 (pt) |
JP (1) | JPH09512816A (pt) |
AT (1) | ATE218350T1 (pt) |
AU (1) | AU693541B2 (pt) |
DE (1) | DE69526937T2 (pt) |
DK (1) | DK0758241T3 (pt) |
ES (1) | ES2177642T3 (pt) |
FI (1) | FI118590B (pt) |
GB (1) | GB9408775D0 (pt) |
HU (1) | HUT74984A (pt) |
IL (1) | IL113566A (pt) |
NO (1) | NO310057B1 (pt) |
NZ (1) | NZ283430A (pt) |
PT (1) | PT758241E (pt) |
TW (1) | TW458779B (pt) |
WO (1) | WO1995030421A1 (pt) |
ZA (1) | ZA953537B (pt) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5646134A (en) * | 1994-04-21 | 1997-07-08 | Merck & Co., Inc. | Alendronate therapy to prevent loosening of, or pain associated with, orthopedic implant devices |
US6117856A (en) * | 1996-02-14 | 2000-09-12 | Binderman; Itzhak | Topical bisphosphonates for prevention of bone resorption |
US5994329A (en) | 1997-07-22 | 1999-11-30 | Merck & Co., Inc. | Method for inhibiting bone resorption |
US6432932B1 (en) | 1997-07-22 | 2002-08-13 | Merck & Co., Inc. | Method for inhibiting bone resorption |
GB2336311A (en) * | 1998-04-15 | 1999-10-20 | Merck & Co Inc | Bisphosphonate Dosing Regimen |
US6137012A (en) | 1998-10-13 | 2000-10-24 | E. I. Du Pont De Nemours And Company | Phosphole and diphosphole ligands for catalysis |
DE69927048T2 (de) | 1998-12-04 | 2006-06-08 | Roche Diagnostics Gmbh | Ibandroinsäure zur förderung der osseointegration der endoprothesen |
EP1150684A4 (en) * | 1999-02-09 | 2005-06-15 | Sloan Kettering Institutefor C | BONE CEMENT ANTI-RESORPTION AND ALLOGENOUS BONE IMPLANTS, AUTOGRAFTS AND XENOGRAFTS |
US6692758B1 (en) * | 1999-08-02 | 2004-02-17 | Toray Industries, Inc. | Insertion stabilizers for implants |
AUPQ232599A0 (en) * | 1999-08-19 | 1999-09-09 | Royal Alexandra Hospital For Children, The | Drug for treating fractures |
SI1296689T1 (sl) | 2000-06-20 | 2006-08-31 | Novartis Ag | Nacin dajanja pacientu bisfosfonatov |
JP4722375B2 (ja) * | 2000-06-20 | 2011-07-13 | ノバルティス アーゲー | ビホスホネートの投与法 |
WO2002004038A1 (en) * | 2000-07-12 | 2002-01-17 | Hopital Orthopedique De La Suisse Romande | Active biocoating for bone implant |
GB0029111D0 (en) * | 2000-11-29 | 2001-01-10 | Novartis Ag | Organic compounds |
CA2372450A1 (en) * | 2001-05-10 | 2001-09-19 | Pharmaceutical Partners Of Canada Inc. | Liquid injectable formulation of disodium pamidronate |
PL399493A1 (pl) * | 2002-05-10 | 2012-11-05 | F. Hoffmann-La Roche Ag | Kwasy bisfosfonowe do leczenia i profilaktyki osteoporozy |
AU2003270196A1 (en) * | 2002-09-16 | 2004-04-30 | Kenneth W. Lyles | Method for preventing or reducing secondary fractures after hip fracture |
US20040138180A1 (en) * | 2002-10-03 | 2004-07-15 | Barr Laboratories, Inc. | Bisphosphonate composition and process for the preparation thereof |
US8071574B2 (en) * | 2005-02-22 | 2011-12-06 | John Dennis Bobyn | Implant improving local bone formation |
AU2007321108A1 (en) * | 2006-11-17 | 2008-05-22 | Besins Healthcare | Pharmaceutical compositions comprising a bisphosphonate compound |
EP1958649A1 (en) * | 2007-02-14 | 2008-08-20 | Graftys | Injectable calcium-phosphate cement releasing a bone resorption inhibitor |
EP2136814A4 (en) * | 2007-03-21 | 2012-05-30 | Univ Duke | MEDICAL KITS AND FORMULATIONS FOR PREVENTING, TREATING OR REDUCING SECONDARY FRACTURES FROM A PREVIOUS FRACTURE |
WO2008152518A2 (en) * | 2007-05-16 | 2008-12-18 | Actavis Group Ptc Ehf | Process for the preparation of risedronic acid or risedronate sodium |
WO2011028737A2 (en) | 2009-09-01 | 2011-03-10 | Duke University | Bisphosphonate compositions and methods for treating heart failure |
US8882740B2 (en) * | 2009-12-23 | 2014-11-11 | Stryker Trauma Gmbh | Method of delivering a biphosphonate and/or strontium ranelate below the surface of a bone |
WO2013074587A1 (en) | 2011-11-16 | 2013-05-23 | Duke University | Bishophonate compositions and methods for treating and/or reducing cardiac dysfunction |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2405254C2 (de) * | 1974-02-04 | 1982-05-27 | Henkel KGaA, 4000 Düsseldorf | Verwendung von 3-Amino-1-Hydroxypropan-1, 1-diphosphonsäure oder ihrer wasserlöslichen Salze bei der Beeinflußung von Calciumstoffwechselstörungen im menschlichen oder tierischen Körper |
US4639338A (en) * | 1984-08-06 | 1987-01-27 | Ciba-Geigy Corporation | Preparation of crystalline disodium 3-amino-1-hydroxypropane-1,1-diphosphonate pentahydrate |
DE10199052I1 (de) * | 1986-11-21 | 2002-01-10 | Novartis Ag | Neue substituierte Alkandiphosphonsaeuren |
JPH05163150A (ja) * | 1991-05-13 | 1993-06-29 | E R Squibb & Sons Inc | アテローム性動脈硬化症の抑制・治療剤 |
US5403829A (en) * | 1993-03-24 | 1995-04-04 | Leiras Oy | Use of bisphosphonates in endo-osteal bone surgery |
US5646134A (en) * | 1994-04-21 | 1997-07-08 | Merck & Co., Inc. | Alendronate therapy to prevent loosening of, or pain associated with, orthopedic implant devices |
-
1994
- 1994-05-04 GB GB9408775A patent/GB9408775D0/en active Pending
-
1995
- 1995-04-24 ES ES95914495T patent/ES2177642T3/es not_active Expired - Lifetime
- 1995-04-24 WO PCT/IB1995/000288 patent/WO1995030421A1/en active IP Right Grant
- 1995-04-24 PT PT95914495T patent/PT758241E/pt unknown
- 1995-04-24 HU HU9603042A patent/HUT74984A/hu unknown
- 1995-04-24 NZ NZ283430A patent/NZ283430A/en not_active IP Right Cessation
- 1995-04-24 US US08/732,324 patent/US5965547A/en not_active Expired - Fee Related
- 1995-04-24 AU AU21466/95A patent/AU693541B2/en not_active Ceased
- 1995-04-24 DE DE69526937T patent/DE69526937T2/de not_active Expired - Fee Related
- 1995-04-24 AT AT95914495T patent/ATE218350T1/de not_active IP Right Cessation
- 1995-04-24 EP EP95914495A patent/EP0758241B1/en not_active Expired - Lifetime
- 1995-04-24 DK DK95914495T patent/DK0758241T3/da active
- 1995-04-24 JP JP7528805A patent/JPH09512816A/ja active Pending
- 1995-05-01 TW TW084104352A patent/TW458779B/zh not_active IP Right Cessation
- 1995-05-01 IL IL11356695A patent/IL113566A/en not_active IP Right Cessation
- 1995-05-03 ZA ZA953537A patent/ZA953537B/xx unknown
-
1996
- 1996-10-22 NO NO964486A patent/NO310057B1/no not_active IP Right Cessation
- 1996-10-28 FI FI964332A patent/FI118590B/fi active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
WO1995030421A1 (en) | 1995-11-16 |
HUT74984A (en) | 1997-03-28 |
FI964332A0 (fi) | 1996-10-28 |
IL113566A (en) | 2002-05-23 |
NO964486D0 (no) | 1996-10-22 |
EP0758241A1 (en) | 1997-02-19 |
AU693541B2 (en) | 1998-07-02 |
EP0758241B1 (en) | 2002-06-05 |
US5965547A (en) | 1999-10-12 |
DE69526937T2 (de) | 2003-01-02 |
IL113566A0 (en) | 1995-08-31 |
NO310057B1 (no) | 2001-05-14 |
ATE218350T1 (de) | 2002-06-15 |
ZA953537B (en) | 1995-11-06 |
DK0758241T3 (da) | 2002-09-23 |
DE69526937D1 (de) | 2002-07-11 |
NZ283430A (en) | 2000-06-23 |
AU2146695A (en) | 1995-11-29 |
ES2177642T3 (es) | 2002-12-16 |
NO964486L (no) | 1996-10-22 |
FI964332A (fi) | 1996-10-28 |
TW458779B (en) | 2001-10-11 |
FI118590B (fi) | 2008-01-15 |
GB9408775D0 (en) | 1994-06-22 |
HU9603042D0 (en) | 1997-01-28 |
JPH09512816A (ja) | 1997-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT758241E (pt) | Utilizacao de certos derivados de acido metanobisfosfonico para impedir o desprendimento de proteses e a migracao de proteses | |
NO952228D0 (no) | Anvendelse av lamotrigin ved behandling av neurologiske lesjoner relatert til traumatiske skader | |
DE69326776D1 (de) | Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress | |
DE69507029T2 (de) | Pharmazeutische zusammensetzungen enthaltend einen opiat antagonist und calcium salze, ihre verwendung zur behandlung von endorphin-vermittelten krankheiten | |
IL113941A (en) | Perfluoroalkyl ketone inhibitors of elastase processes for making the same and pharmaceutical compositions containing them | |
FI972308A0 (fi) | 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi | |
DE69431601D1 (de) | Neue verwendung von dexmedetomidin | |
BR9509975A (pt) | Formulação farmacêutica | |
IT1282736B1 (it) | Uso di derivati del p-amminofenolo per preparare composizioni farmaceutiche utili nel trattamento di malattie neurodegenerative | |
BG105275A (en) | Tan-1057 derivatives | |
EE9700366A (et) | Angiotensiini II tüüp 1 retseptori antagonistide kasutamine düspeptiliste sümptomite profülaktikas ja/või ravis kasutatava ravimi valmistamiseks ja angiotensiini II tüüp 1 retseptori antagoniste sisaldavad ravimpreparaadid | |
EA199800953A1 (ru) | Компонент в, используемый в качестве рубцующего агента, содержащая его фармацевтическая композиция и способ лечения | |
MX9605327A (es) | Uso de ciertos derivados de acido metanbisfosfonico para prevenir el aflojamiento de las protesis y la emigracion de las protesis. |